Skip to main content

Digital

Publication, Part of

Hospital Prescribing - England, 2011

Official statistics
Publication Date:
Geographic Coverage:
England
Geographical Granularity:
Regions, Country, Strategic Health Authorities
Date Range:
01 Jan 2011 to 31 Dec 2011

Summary

This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. The specific area covered this year is medicines for HIV and AIDs.

 

An error has been identified with the figures given in table 4 for alendronic acid and rosiglitazone in the original publication released in November 2012. Corrected versions of the report and the Excel spreadsheet replaced the incorrect versions on 25th March 2013

Highlights

  • Total prescribing costs in 2011 were £13.1 billion
  • In 2011 hospital use accounted for 33.3 per cent of the total cost, up from 31.79 percent in 2010.
  • The cost of medicines rose by 1.9 per cent overall but by 6.9 per cent in hospitals
  • Of the drugs positively appraised by NICE, the greatest overall cost was for atorvastatin but adalimumab incurred the greatest cost in hospitals.
  • HIV/AIDS treatment is given predominantly through hospitals but while the total cost varies widely, cost per patient is similar

Resources

Last edited: 2 November 2018 2:49 pm